Cartesian Therapeutics Inc
RNAC6.720USD
-0.500-6.93%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
174.74MMarket Cap
LossP/E TTM
Cartesian Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
38.91M
49.64%
EPS(YoY)
-4.48
90.99%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its total revenue reached 38.91M, with a year-on-year change of 49.64%.
What is the Earnings Per Share (EPS) of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -4.481, with a year-on-year change of 90.99%.
What is the net income of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its net income was -77.42M, with a year-on-year change of 69.90%.
What is the net margin of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its net profit margin was -198.97%, with a year-on-year change of 76.45%.
What is the gross margin of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -20.92%, with a year-on-year change of 77.58%.
What is the operating profit of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its operating profit was -36.32M, with a year-on-year change of 57.63%.
What are the current assets of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its current assets were 216.63M, with a year-on-year change of 138.76%.
What are the total assets of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its total assets of Cartesian Therapeutics Inc were 435.02M, with a year-on-year change of 42.61%.
What are the total liabilities of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its total liabilities of Cartesian Therapeutics Inc were 441.82M, with a year-on-year change of -0.64%.
What is the total equity of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its total equity of Cartesian Therapeutics Inc was -6.80M, with a year-on-year change of 95.13%.
What is the net operating income of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its net operating income of Cartesian Therapeutics Inc was -77.42M, with a year-on-year change of 64.76%.
What is the net investment of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its net investment of Cartesian Therapeutics Inc was -8.74M, with a year-on-year change of -125.26%.
What is the net financing of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2024 earnings report, its net financing of Cartesian Therapeutics Inc was 168.43M, with a year-on-year change of 1381.31%.
